Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study.
Catto JW, Robinson MC, Albertsen PC, Goepel JR, Abbod MF, Linkens DA, Davis M, Rosario DJ, Warren AY, Varma M, Griffiths DF, Grigor KM, Mayer NJ, Oxley JD, Deshmukh NS, Lane JA, Metcalfe C, Donovan JL, Neal DE, Hamdy FC; ProtecT study group.
Catto JW, et al.
Br J Cancer. 2011 Sep 27;105(7):931-7. doi: 10.1038/bjc.2011.314. Epub 2011 Aug 23.
Br J Cancer. 2011.
PMID: 21863028
Free PMC article.
Clinical Trial.